Geneos cancer vaccine shrinks liver tumors in small trial

Nearly a third of patients with advanced liver cancer who received a personalized vaccine developed by Geneos Therapeutics along with an immunotherapy drug in a small, early trial saw their tumors shrink, U.S. researchers reported on Sunday. The result was roughly twice the response typically seen…#geneostherapeutics #sandiego #naturemedicine #merckandco #markyarchoan #merck #keytruda #yarchoan #rna #geneos
Source: Reuters: Health - Category: Consumer Health News Source Type: news